A Multicenter Adaptive Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults

Brief description of study

This study will compare the effect of giving remdesivir in combination with baricitinib and a placebo infusion or remdesivir in combination with dexamethasone and a placebo tablet in adult patients that are hospitalized with COVID-19. The drugs have been tested before in humans with COVID-19 and other diseases. This study will examine whether these drugs are safe for use in humans with COVID-19 and see if they together can improve patients health when they are sick with COVID-19.

If you are registered as a volunteer, please login to the dashboard to send referrals.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.